Arrowhead Business and Investment Decisions, LLC ("Arrowhead") initiated coverage and published a Due Diligence and Valuation Report on Accurexa Inc. ("Accurexa" or the "Company") (OTCQB:ACXA), a biotechnology company focused on developing and commercializing novel neurological therapies, on December 23, 2014.